Who owns Exagen Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Exagen with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Exagen stock

Who bought or sold Exagen Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cowen And Company 899k $1.8M 7% Dec 2023
 View chart
Daniel D. Thurber 787k $1.3M -7% Mar 2024
 View chart
Perkins Capital Management 509k $1.0M 93% Dec 2023
 View chart
Vanguard Group 491k $977k 0% Dec 2023
 View chart
Nantahala Capital Management 97k $193k -9% Dec 2023
 View chart
Penbrook Managment 77k $122k 1% Mar 2024
 View chart
UBS Group 62k $124k -52% Dec 2023
 View chart
Dimensional Fund Advisors 36k $72k -34% Dec 2023
 View chart
Millennium Management 24k $47k -24% Dec 2023
 View chart
Citadel Advisors 21k $42k 100% Dec 2023
 View chart
Palumbo Wealth Management 18k $29k 100% Mar 2024
 View chart
First Bank & Trust 14k $22k 0% Mar 2024
 View chart
Hanson McClain Advisors 7.0k $11k 0% Mar 2024
 View chart
Bank of America Corporation 6.0k $12k -12% Dec 2023
 View chart
Barclays 5.1k $10k 0% Dec 2023
 View chart
Wells Fargo & Company 2.5k $4.9k 0% Dec 2023
 View chart
Royal Bank of Canada 542.00 $999.990000 -85% Dec 2023
 View chart
Jpmorgan Chase & Co 25.00 $50.000000 -99% Dec 2023
 View chart

Who sold out of Exagen?

Fund or Company Name Date Sold Shares Held Valued At
Advisor Group Holdings Sep 2023 650.00 $1.6k
State of Wyoming Sep 2023 649.00 $1.6k